Document is current

Article History

Received: 29 April 2025

Accepted: 8 August 2025

First Online: 25 August 2025

Declarations

:

: G.Y. is a consultant and advisory Board member for Sanofi, Regeneron, Pfizer, Galderma, Novartis, Eli Lilly, AbbVie, Arcutis, Abbvie, Kiniksa, Trevi, Pierre Fabre, LEO Pharma, Escient, Celldex,Kamari and Vifor ; and has received research support from Abbvie, Pfizer, Sanofi, Regeneron, LEO Pharma, Eli Lilly, Kiniksa, Novartis, Escient, , Galderma and Celldex. G.Y. is an Editorial Board member of the American Journal of Clinical Dermatology. He was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.

: No new datasets were generated or analyzed during the current study. All data discussed are derived from previously published literature and are available within the referenced sources.

: Not applicable

: Not applicable.

: The authors obtained consent from patients for their anonymized photos to be published in print and online and with the understanding that this information may be publicly available.

: Not applicable.

: M.M. was responsible for the primary literature review and drafting of the manuscript. L.F.A. and M.A. contributed to the literature review and assisted with manuscript editing. G.Y. supervised the project, provided critical revisions, and ensured clinical and academic accuracy. All authors have read and approved the final version of the manuscript and agree to be accountable for all aspects of the work.